UK Patients To Benefit From Access To Innovative Lung Cancer Treatment
The National Institute for Health and Clinical Excellence (NICE) have today published their
Diagnostics
Pages: 1 [2]
Evidence Grows For Multiple Drug Therapy Use With Tracleer(R) (bosentan) As First Line Therapy
Abstract 1012. 9. Farber HW; Loscalzo J. Mechanisms of disease: pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1655-1665. 10. Humbert M, et al. Treatment of pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1425-1436. 11. Humbert M, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2004; 43: Suppl. 12: 13S-24S. Actelion LtdPages: 1 [2]